MGRX

3.39% 0.0152

Vorhandelsmarkt: .46 -0.0041 -0.88%

Mangoceuticals Inc (MGRX)

Überblick Nachrichten Preisverlauf Forum Prognose

Schlusskurs vom Vortag:

24-Stunden-Volumen:

Relative Volume:

Marktkapitalisierung:

Nettoeinkommen (Verlust:

Netto-Cashflow:

1W Leistung:

1M Leistung:

6M Leistung:

1J Leistung:

1-Tages-Spanne:

1-Wochen-Bereich:

52-Wochen-Spanne:

Mangoceuticals Inc Stock (MGRX) Company Profile

Mangoceuticals Inc

Healthcare (1068)

(833) 626-4679

15110 DALLAS PKWY, SUITE 600, DALLAS

Nächster Verdiensttermin

Neueste SEC-Einreichungen

MGRX's Discussions on Twitter

Compare MGRX vs VEEV, TEM, BTSG, TXG, HNGE

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
MGRX Mangoceuticals Inc	0.4641	10.01M	414.60K	-19.21M	-4.89M	-1.6207
VEEV Veeva Systems Inc	274.84	44.50B	3.32B	941.65M	1.64B	5.6161
TEM Tempus Ai Inc	82.24	14.93B	1.36B	-302.91M	-219.93M	-1.7182
BTSG Brightspring Health Services Inc	56.02	11.08B	13.65B	169.86M	412.12M	1.0758
TXG 10 X Genomics Inc	84.11	10.96B	638.78M	-22.66M	122.18M	-0.1744
HNGE Hinge Health Inc	91.98	7.42B	646.34M	-512.40M	202.76M	-6.6871

Mangoceuticals Inc Aktie (MGRX) Neueste Nachrichten

Finanzdaten der Mangoceuticals Inc-Aktie (MGRX)

Mangoceuticals Inc (MGRX)

Mangoceuticals Inc Stock (MGRX) Company Profile

Compare MGRX vs VEEV, TEM, BTSG, TXG, HNGE

Mangoceuticals Inc Aktie (MGRX) Neueste Nachrichten

MGRX Q3 2025 Earnings: Per-Share Loss of $0.69 as Shares Slip 4%Earnings Growth Analysis - dars.gov.et

Mangoceuticals Terminates Planned Business Combination with Nuclea - The Globe and Mail

Mangoceuticals And Nuclea Energy Terminate Business Combination Agreement On August 19 - TradingView

Mangoceuticals Terminates Nuclea Energy Business Combination After $15 Million PIPE Not Secured - TradingView

Mangoceuticals Company Profile & Introduction - Moomoo

MGRX Stock Alert: Halper Sadeh LLC is Investigating Whether Mangoceuticals, Inc. is Obtaining a Fair Price for its Shareholders - businesswire.com

MANGOCEUTICALS, INC. Q2 2026: Revenue $68.76K, EPS $(0.09) — 10-Q Summary - TradingView

Mangoceuticals (MGRX) Q2 2026 loss shrinks while cash and revenue fall - Stock Titan

Mangoceuticals, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com

12 Consumer Staples Stocks Moving In Thursday's After-Market Session - Benzinga

Mangoceuticals: Acquisition of Moltex Brings Advanced Nuclear R&D, Backed by More Than C$96M in Private Investment and Public Funding From Canada and the DOE >MGRX - Moomoo

Nuclea’s planned Moltex deal could add 80 nuclear patents - Stock Titan

Mangoceuticals (MGRX) Earnings Date and Reports 2026 - MarketBeat

MGRX Q3 2025 Earnings: -$0.69 Per Share Loss and 8.16% Stock Decline Highlight Ongoing ChallengesEPS Surprise History - dars.gov.et

Why is Mangoceuticals stock surging today? - Investing.com India

On Thursday, there are stocks with unusual volume. Let's take a look. - ChartMill

Why is Mangoceuticals stock surging today? By Investing.com - Investing.com South Africa

Mangoceuticals’ Merger Partner, Nuclea Energy Inc., Signs MOU with New Mining Co. to Advance Behind-the-Meter Modular Reactor Deployment for High-Density Computing Infrastructure - The Manila Times

Mangoceuticals' Merger Partner, Nuclea Energy Inc., Signs MOU With New Mining Co. to Advance Behind-the-Meter Modular Reactor Deployment for High-Density Computing Infrastructure - Moomoo

Mangoceuticals (MGRX) merger partner Nuclea inks Utah nuclear test reactor MOU - Stock Titan

Mangoceuticals (MGRX) Stock Jumps Over 49% After Hours: Here's Why - Benzinga

Mangoceuticals merger partner Nuclea signs MOU with New Mining on modular reactor power for data centers - Bitget

Mangoceuticals Wins Nasdaq Extension Amid Nuclea Deal Progress - The Globe and Mail

Wondering what's happening in today's after-hours session? - ChartMill

Mangoceuticals’ Merger Partner, Nuclea Energy (“Nuclea”), Executes MOU with Utah Office of Energy Development - Yahoo Finance

Mangoceuticals (NASDAQ: MGRX) wins more time on Nasdaq rules, advances Nuclea deal - Stock Titan

Mangoceuticals Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Requirement and Comments on Nuclea Energy Business Combination - The Manila Times

Mangoceuticals Inc. (MGRX) Slides 15% to $0.45 as Selling Pressure IntensifiesSmart Money Flow Stocks - dars.gov.et

$Mangoceuticals (MGRX.US)$ - Moomoo

MGRX Q3 2025 Earnings: Reported EPS of -$0.69 as Shares Rally 89.75%Earnings Forecast Report - vinanet.vn

Mangoceuticals, Inc. Common Stock (NASDAQ: MGRX) Stock Price, News & Analysis - Kalkine

Microcaps MGRX, PRSO, IGC, KUST In the News to Watch - openPR.com

That’s quite fortunate! - Moomoo

$Mangoceuticals (MGRX.US)$ wow finally CB ⬆️ [Grin][Drool][Cool Guy][Angry][Tongue] - moomoo.com

$Mangoceuticals (MGRX.US)$ sold a tad early. but definitely looking for another entry! - Moomoo

Form 4 Mangoceuticals Inc For: 30 July By Investing.com - Investing.com Canada

Nuclea Energy to go public via merger with Mangoceuticals By Investing.com - Investing.com Nigeria

Nuclea Energy Enters Definitive Business Combination Agreement with Mangoceuticals, Establishing a Path to a Nasdaq Public Listing to Advance the Morpheus Microreactor - TMX Newsfile

Nuclea Energy Inc: Nuclea Energy Enters Definitive Business Combination Agreement with Mangoceuticals, Establishing a Path to a Nasdaq Public Listing to Advance the Morpheus Microreactor - FinanzNachrichten.de

Mangoceuticals agrees to merge with nuclear microreactor developer - Investing.com Nigeria

Mangoceuticals agrees to merge with nuclear microreactor developer By Investing.com - Investing.com Canada

Jacob D. Cohen to Leave CEO Role at Mangoceuticals, Becomes President in Consulting Role - TradingView

Nuclea Energy and Mangoceuticals Announce Merger to List Advanced Microreactor Developer on Nasdaq - Kalkine Media

Mangoceuticals Inc (MGRX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey

Mangoceuticals Inc (MGRX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey

Mangoceuticals Inc (MGRX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

Mangoceuticals Inc (MGRX) Cash Flow - TradingKey

Mangoceuticals Inc (MGRX) Income Statement - TradingKey

MGRX|Mangoceuticals Inc|Price:0.542|Chg%:-0.001 - TradingKey

MGRX|Mangoceuticals Inc|Price:0.521|Chg%:-0.037 - TradingKey

Mangoceuticals (MGRX) Slips 6.58% as Stock Tests Critical Support LevelsDaily Profile - dars.gov.et

Finanzdaten der Mangoceuticals Inc-Aktie (MGRX)

Umsatz

Nettogewinn

Free Cashflow

ENV

Ähnlich wie MGRX